Long-Term Outcomes of Stereotactic Radiosurgery for Pineocytomas: An International Multicenter Study.

IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Neurosurgery Pub Date : 2024-11-07 DOI:10.1227/neu.0000000000003261
Andréanne Hamel, Jean-Nicolas Tourigny, Ajay Niranjan, L Dade Lunsford, Zhishuo Wei, Priyanka N Srinivasan, Roman Liscak, Jaromir May, Nuria Martínez Moreno, Roberto Martínez Álvarez, Cheng-Chia Lee, Huai-Che Yang, Manjul Tripathi, Narendra Kumar, Elad Mashiach, Douglas Kondziolka, Robert G Briggs, Cheng Yu, Gabriel Zada, Andrea Franzini, Guido Pecchioli, Gregory N Bowden, Samantha Dayawansa, Jason Sheehan, David Mathieu
{"title":"Long-Term Outcomes of Stereotactic Radiosurgery for Pineocytomas: An International Multicenter Study.","authors":"Andréanne Hamel, Jean-Nicolas Tourigny, Ajay Niranjan, L Dade Lunsford, Zhishuo Wei, Priyanka N Srinivasan, Roman Liscak, Jaromir May, Nuria Martínez Moreno, Roberto Martínez Álvarez, Cheng-Chia Lee, Huai-Che Yang, Manjul Tripathi, Narendra Kumar, Elad Mashiach, Douglas Kondziolka, Robert G Briggs, Cheng Yu, Gabriel Zada, Andrea Franzini, Guido Pecchioli, Gregory N Bowden, Samantha Dayawansa, Jason Sheehan, David Mathieu","doi":"10.1227/neu.0000000000003261","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Pineocytomas are grade 1 tumors arising from the pineal parenchyma. Gross total resection can potentially cure these benign lesions but can be associated with morbidity. This study was designed to provide multi-institutional data to evaluate the results of stereotactic radiosurgery (SRS) for pineocytomas.</p><p><strong>Methods: </strong>Centers participating in the International Radiosurgery Research Foundation were asked to review their database and provide data for patients who had SRS for histology confirmed grade 1 pineocytomas, for whom clinical and imaging follow-up of at least 6 months was available.</p><p><strong>Results: </strong>In total, 38 patients underwent SRS as part of the management of a pineocytoma. The median age at SRS was 39 years (range 8-76). SRS was performed as primary approach in 68%, adjuvant after partial resection 19%, and at recurrence in 13% of patients. The median margin dose was 15 Gy (range 11-25 Gy). The median treatment volume was 3.35 cc (range 0.1-17.9 cc). Local tumor control was achieved in 92% of patients, with a mean actuarial progression-free survival of 21.6 years (median not reached). At last follow-up, 82% were still controlled, 8% had local recurrence, and 10% had cerebrospinal fluid dissemination. Tumor control was significantly better when SRS was used as primary care compared with the adjuvant or recurrent setting (P = .016). Five patients (13%) died during follow-up, all from tumor progression. The actuarial mean survival duration was 24.3 years, with a 5-year survival rate of 91%, and an estimated rate of 76% at 29 years. Larger tumor volume at SRS was found to be correlated to increased risk of death (P = .045). Transient symptomatic adverse radiation effects were observed in 4 patients (11%).</p><p><strong>Conclusion: </strong>SRS appears safe and effective for the management of pineocytomas. Long-term tumor control is achieved in most cases. SRS can be offered to selected patients as an alternative to surgical resection.</p>","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":" ","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1227/neu.0000000000003261","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Pineocytomas are grade 1 tumors arising from the pineal parenchyma. Gross total resection can potentially cure these benign lesions but can be associated with morbidity. This study was designed to provide multi-institutional data to evaluate the results of stereotactic radiosurgery (SRS) for pineocytomas.

Methods: Centers participating in the International Radiosurgery Research Foundation were asked to review their database and provide data for patients who had SRS for histology confirmed grade 1 pineocytomas, for whom clinical and imaging follow-up of at least 6 months was available.

Results: In total, 38 patients underwent SRS as part of the management of a pineocytoma. The median age at SRS was 39 years (range 8-76). SRS was performed as primary approach in 68%, adjuvant after partial resection 19%, and at recurrence in 13% of patients. The median margin dose was 15 Gy (range 11-25 Gy). The median treatment volume was 3.35 cc (range 0.1-17.9 cc). Local tumor control was achieved in 92% of patients, with a mean actuarial progression-free survival of 21.6 years (median not reached). At last follow-up, 82% were still controlled, 8% had local recurrence, and 10% had cerebrospinal fluid dissemination. Tumor control was significantly better when SRS was used as primary care compared with the adjuvant or recurrent setting (P = .016). Five patients (13%) died during follow-up, all from tumor progression. The actuarial mean survival duration was 24.3 years, with a 5-year survival rate of 91%, and an estimated rate of 76% at 29 years. Larger tumor volume at SRS was found to be correlated to increased risk of death (P = .045). Transient symptomatic adverse radiation effects were observed in 4 patients (11%).

Conclusion: SRS appears safe and effective for the management of pineocytomas. Long-term tumor control is achieved in most cases. SRS can be offered to selected patients as an alternative to surgical resection.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
立体定向放射外科治疗松果体瘤的长期疗效:一项国际多中心研究。
背景和目的:松果体细胞瘤是松果体实质产生的一级肿瘤。大体全切除术有可能治愈这些良性病变,但也可能与发病率有关。本研究旨在提供多机构数据,评估立体定向放射外科手术(SRS)治疗松果体瘤的效果:方法:要求参与国际放射外科研究基金会(International Radiosurgery Research Foundation)的中心审查其数据库,并提供因组织学确诊的 1 级松果体细胞瘤而接受 SRS 治疗的患者数据,这些患者至少接受了 6 个月的临床和影像学随访:共有 38 名患者接受了 SRS 作为松果体细胞瘤治疗的一部分。接受 SRS 时的中位年龄为 39 岁(8-76 岁)。68%的患者接受了SRS治疗,19%的患者在部分切除术后接受了辅助治疗,13%的患者在复发时接受了SRS治疗。中位边缘剂量为15 Gy(范围为11-25 Gy)。中位治疗量为 3.35 cc(范围为 0.1-17.9 cc)。92%的患者实现了局部肿瘤控制,平均精算无进展生存期为21.6年(中位数未达到)。在最后一次随访中,82%的患者肿瘤仍得到控制,8%的患者出现局部复发,10%的患者出现脑脊液播散。与辅助治疗或复发治疗相比,SRS作为主要治疗手段时,肿瘤控制效果明显更好(P = .016)。五名患者(13%)在随访期间死亡,均死于肿瘤进展。精算平均生存期为 24.3 年,5 年生存率为 91%,29 年生存率估计为 76%。研究发现,SRS时肿瘤体积越大,死亡风险越高(P = .045)。4名患者(11%)出现了短暂的放射不良反应症状:结论:SRS治疗松果体细胞瘤似乎安全有效。大多数病例都能实现长期肿瘤控制。SRS 可作为手术切除的替代方案提供给选定的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neurosurgery
Neurosurgery 医学-临床神经学
CiteScore
8.20
自引率
6.20%
发文量
898
审稿时长
2-4 weeks
期刊介绍: Neurosurgery, the official journal of the Congress of Neurological Surgeons, publishes research on clinical and experimental neurosurgery covering the very latest developments in science, technology, and medicine. For professionals aware of the rapid pace of developments in the field, this journal is nothing short of indispensable as the most complete window on the contemporary field of neurosurgery. Neurosurgery is the fastest-growing journal in the field, with a worldwide reputation for reliable coverage delivered with a fresh and dynamic outlook.
期刊最新文献
Evaluation of 2 Surgical Techniques-Transposition Versus Interposition Microvascular Decompression for Hemifacial Spasm: A Systematic Review of 19 437 Patients. Outcome of Fourth Ventricular Hemorrhage in Ruptured Brain Aneurysms: Impact of Active Blood Clearance and Delayed Cerebral Ischemia Prevention. Perioperative Glucagon-Like Peptide-1 Agonist Use and Rates of Pseudarthrosis After Single-Level Lumbar Fusion: A Large Retrospective Cohort Study. Postoperative Blood Pressure Goals After Craniotomy for Tumor Resection: A National Survey. Prediction of Shunt Malfunction Using Automated Ventricular Volume Analysis and Radiomics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1